Head to head for first-timers
Hers vs Zealthy
Hers and Zealthy both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
Hers
Higher scoreRank #13 for first-timers · Grade B−
Mama-Match
Best for: Moms who want a familiar, women-focused brand and are comfortable budgeting for a separate membership on top of the posted medication price.
Visit HersZealthy
Rank #293 for first-timers · Grade C
Mama-Match
Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.
Visit ZealthyThe verdict for a first step
Hers edges out Zealthy on the Mama-Match Score, 82 to 39 (B− vs C). Moms who want a familiar, women-focused brand and are comfortable budgeting for a separate membership on top of the posted medication price.
Zealthy is still a genuine option — ⛔ FDA warning letter #716501 (Sept. 2025) and, in April 2026, the FTC and DOJ moved to seize the company and freeze its assets. Read that first. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | Hers | Zealthy |
|---|---|---|
| Mama-Match Score | 82/100 · B− | 39/100 · C |
| Overall rank | #13 | #293 |
| Semaglutide | $298/mo all-in (medication + membership) | $135/mo |
| Tirzepatide | $448/mo all-in (medication + membership) | $225/mo |
| Coverage | All 50 states | Most states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Mama-Match
Hers
Rank #13 · Grade B−
What we like
- Now sells FDA-approved brand medication (Wegovy, Zepbound) instead of compounded semaglutide
- An explicitly women-focused brand that many moms already recognize and trust
- Nationwide, with a very smooth app-guided signup and an oral/sublingual option
The caveats
- ⛔ FDA warning letter #716825, dated September 9, 2025, to Hims & Hers Health, Inc. dba Hers — its sister brand, Hims, got its own the same day (#716567)
- The 'from $149/mo' price is medication only — a separate $149/mo membership (billed apart, $39 the first month) nearly doubles the real ongoing cost
- Less emphasis on labs and metabolic detail behind the polished brand
Mama-Match
Zealthy
Rank #293 · Grade C
What we like
- Low, published monthly pricing for semaglutide and tirzepatide
- Coverage in most states with a fast, low-friction signup
- Straightforward compounded model — you see the cost before you commit
The caveats
- ⛔ FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, for unlawful sale of unapproved and misbranded drugs over the internet — the letter names its own site
- April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
- The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Hers and Zealthy with the other providers we review for women.
Or browse the full comparison hub.